EPAS1 and fatty liver disease: It is noteworthy that, although disruption of pVhl activates HIF and leads to upregulation of both HIF-1α and HIF-2α target genes31, 32, the induction of hepatic steatosis and inflammation seems to be exclusively HIF-2α-dependent in this model29, 30.